- Home
- ACIU vs ATLO Comparison
ACIU vs ATLO Comparison
Compare ACIU & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- ATLO
- Stock Information
- Founded
- ACIU 2003
- ATLO 1903
- Country
- ACIU Switzerland
- ATLO United States
- Employees
- ACIU N/A
- ATLO N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- ATLO Major Banks
- Sector
- ACIU Health Care
- ATLO Finance
- Exchange
- ACIU Nasdaq
- ATLO Nasdaq
- Market Cap
- ACIU 189.1M
- ATLO 158.4M
- IPO Year
- ACIU 2016
- ATLO N/A
- Fundamental
- Price
- ACIU $2.07
- ATLO $18.58
- Analyst Decision
- ACIU Strong Buy
- ATLO
- Analyst Count
- ACIU 1
- ATLO 0
- Target Price
- ACIU $12.00
- ATLO N/A
- AVG Volume (30 Days)
- ACIU 139.5K
- ATLO 17.4K
- Earning Date
- ACIU 08-05-2025
- ATLO 08-08-2025
- Dividend Yield
- ACIU N/A
- ATLO 4.31%
- EPS Growth
- ACIU N/A
- ATLO 14.69
- EPS
- ACIU N/A
- ATLO 1.27
- Revenue
- ACIU $32,014,254.00
- ATLO $55,041,000.00
- Revenue This Year
- ACIU N/A
- ATLO N/A
- Revenue Next Year
- ACIU $533.21
- ATLO N/A
- P/E Ratio
- ACIU N/A
- ATLO $14.68
- Revenue Growth
- ACIU 91.20
- ATLO 6.77
- 52 Week Low
- ACIU $1.43
- ATLO $15.69
- 52 Week High
- ACIU $4.26
- ATLO $22.03
- Technical
- Relative Strength Index (RSI)
- ACIU 56.20
- ATLO 63.91
- Support Level
- ACIU $1.65
- ATLO $17.19
- Resistance Level
- ACIU $2.17
- ATLO $17.67
- Average True Range (ATR)
- ACIU 0.17
- ATLO 0.41
- MACD
- ACIU -0.01
- ATLO 0.10
- Stochastic Oscillator
- ACIU 70.37
- ATLO 94.25
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.